What are regulatory T cells (Treg) regulating in cancer and why?
- 1 August 2012
- journal article
- review article
- Published by Elsevier BV in Seminars in Cancer Biology
- Vol. 22 (4), 327-334
- https://doi.org/10.1016/j.semcancer.2012.03.004
Abstract
No abstract availableKeywords
Funding Information
- NCI (PO1-CA109688)
This publication has 121 references indexed in Scilit:
- Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsetsJournal of Immunological Methods, 2011
- Camouflage and sabotage: tumor escape from the immune systemCancer Immunology, Immunotherapy, 2011
- The prognostic impact of anti-cancer immune response: a novel classification of cancer patientsSeminars in Immunopathology, 2011
- Chemotherapy and radiotherapy: Cryptic anticancer vaccinesSeminars in Immunology, 2010
- Regulatory T Cells in CancerAdvances in Cancer Research, 2010
- Lymphocytes in cancer development: Polarization towards pro-tumor immunityCytokine & Growth Factor Reviews, 2009
- Isolation of functional human regulatory T cells (Treg) from the peripheral blood based on the CD39 expressionJournal of Immunological Methods, 2009
- Inflammation and Cancer: IL-6 and STAT3 Complete the LinkCancer Cell, 2009
- CD39 and control of cellular immune responsesPurinergic Signalling, 2007
- Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patientsCancer Immunology, Immunotherapy, 2006